RankAlpha logo
Back to Rankings

HALO

Halozyme TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
HALO vs peer average
63/100
HALO vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 5 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Broad large-cap biologics comp rather than a clean Halozyme analog; useful mainly as a reference for how subcutaneous biologic adoption and partner execution can affect platform royalty opportunity.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
HALO
Halozyme Therapeutics
AMGN
Amgen
Grade
B
C
Momentum
47
36
Value
67
64
Sentiment
65
47
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs AMGN

HALO / AMGN
Grade Position
In line
HALO vs. peer average (B vs. C)
63/100
Momentum
47
HALO
Value
67
HALO
Sentiment
65
HALO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HALO
1
AMGN
AMGN
C
60/100
+1
2
GILD
GILD
C
60/100
+1
3
TECH
Bio-Techne Corp Common
D
40/100
+2
4
CORT
Corcept Therapeutics Inc. Common
B
80/100
Even
5
IBRX
ImmunityBio Inc Common
A
100/100
-1
AMGN is the first peer returned for this comparison set.